CONSTRONICS INFRA
|
CONSTRONICS INFRA Last 5 Year Financial Ratios History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 2.50 | 0.99 | 0.08 | 0.24 | -0.11 |
| CEPS(Rs) | 2.65 | 1.03 | 0.11 | 0.26 | -0.11 |
| DPS(Rs) | - | - | - | - | - |
| Book NAV/Share(Rs) | 24.30 | 1.34 | 0.34 | 0.27 | 0.02 |
| Tax Rate(%) | 28.41 | 7.14 | 40.30 | -75.15 | - |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 6.21 | 41.45 | 12.38 | 5.40 | -5.46 |
| EBIT Margin(%) | 8.86 | 101.11 | 12.88 | 5.03 | -5.10 |
| Pre Tax Margin(%) | 8.58 | 99.88 | 11.55 | 4.59 | -5.10 |
| PAT Margin (%) | 6.14 | 92.75 | 6.90 | 8.05 | -5.10 |
| Cash Profit Margin (%) | 6.51 | 96.48 | 9.82 | 8.75 | -5.04 |
| Performance Ratios | |||||
| ROA(%) | 11.43 | 18.93 | 5.30 | 17.40 | -8.66 |
| ROE(%) | 19.94 | 118.08 | 25.70 | 167.27 | -138.79 |
| ROCE(%) | 19.99 | 20.90 | 9.93 | 11.22 | -9.14 |
| Asset Turnover(x) | 1.86 | 0.20 | 0.77 | 2.16 | 1.70 |
| Sales/Fixed Asset(x) | 63.98 | 3.56 | 3.82 | 20.00 | 394.56 |
| Working Capital/Sales(x) | 2.95 | 0.13 | 1.30 | 11.96 | 13.52 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 0.02 | 0.28 | 0.26 | 0.05 | - |
| Receivable days | 21.02 | 49.52 | 43.09 | 6.67 | - |
| Inventory Days | 35.70 | 214.42 | - | - | - |
| Payable days | 348.21 | 151.95 | 25.05 | 5.04 | 3.87 |
| Valuation Parameters | |||||
| PER(x) | 28.12 | 45.58 | 77.71 | - | - |
| PCE(x) | 26.55 | 43.82 | 54.56 | - | -61.22 |
| Price/Book(x) | 2.89 | 33.84 | 17.70 | - | 275.29 |
| Yield(%) | - | - | - | - | - |
| EV/Net Sales(x) | 1.59 | 42.78 | 5.62 | 3.69 | 3.52 |
| EV/Core EBITDA(x) | 17.22 | 40.80 | 35.59 | 64.24 | -69.92 |
| EV/EBIT(x) | 17.93 | 42.31 | 43.67 | 73.30 | -69.11 |
| EV/CE(x) | 2.09 | 5.09 | 4.69 | 6.98 | 6.24 |
| M Cap / Sales | 1.73 | 42.27 | 5.36 | - | 3.08 |
| Growth Ratio | |||||
| Net Sales Growth(%) | 6,498.65 | -5.88 | -62.22 | 42.33 | -18.94 |
| Core EBITDA Growth(%) | 480.84 | 524.44 | 4.01 | 262.16 | -181.23 |
| EBIT Growth(%) | 478.43 | 638.98 | -3.29 | 240.49 | -182.33 |
| PAT Growth(%) | 337.10 | 1,165.90 | -67.62 | 324.68 | -183.50 |
| EPS Growth(%) | 151.50 | 1,166.11 | -67.63 | 324.72 | -183.49 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | - | 5.73 | 2.96 | 4.96 | 46.08 |
| Current Ratio(x) | 2.91 | 53.65 | 5.87 | 3.30 | 2.98 |
| Quick Ratio(x) | 1.86 | 49.49 | 5.87 | 3.30 | 2.98 |
| Interest Cover(x) | 31.49 | 82.22 | 9.70 | 11.51 | - |
| Total Debt/Mcap(x) | - | 0.17 | 0.17 | - | 0.17 |
Compare Financial Ratios of peers of CONSTRONICS INFRA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CONSTRONICS INFRA | ₹76.3 Cr | 2.2% | -6% | -51.6% | Stock Analytics | |
| MAX HEALTHCARE INSTITUTE | ₹101,645.0 Cr | -3.3% | -7.1% | -7.5% | Stock Analytics | |
| APOLLO HOSPITALS ENTERPRISE | ₹101,262.0 Cr | -1.8% | -3.4% | -3.6% | Stock Analytics | |
| FORTIS HEALTHCARE | ₹66,704.3 Cr | -2.1% | -2.4% | 28.8% | Stock Analytics | |
| NARAYANA HRUDAYALAYA | ₹38,643.6 Cr | 0.8% | -1% | 41% | Stock Analytics | |
| GLOBAL HEALTH | ₹31,877.2 Cr | -0.5% | -4.7% | 5.9% | Stock Analytics | |
CONSTRONICS INFRA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CONSTRONICS INFRA | 2.2% |
-6% |
-51.6% |
| SENSEX | -0.4% |
-0.6% |
8.6% |
You may also like the below Video Courses
